AnaptysBio Secures $2,022,117 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0d658caf-87b7-4ae1-87d7-21c6e9130ab3 - Date
10/11/2013 - Company Name
AnaptysBio - Mailing Address
10421 Pacific Center Court San Diego, CA 92121 - Company Description
Founded in 2005, AnaptysBio is a privately-held therapeutic antibody company and the leader in the use of somatic hypermutation, or SHM, for antibody discovery and optimization. SHM is the body’s natural process for generating potent antibodies to fight disease. - Website
http://www.anaptysbio.com - Transaction Type
Debt - Transaction Amount
$2,022,117 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation. - M&A Terms
- Venture Investor
Undisclosed
